BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• FDA

  Lupin Ltd. Receives US FDA Approval For Cefprozil Tablets

  December 12, 2005

   · 

  1 min read
• Business

  Abbott Laboratories Declares 328th Consecutive Quarterly Dividend

  December 12, 2005

   · 

  1 min read
• Business

  CardioDynamics International Corporation Announces Senior Management Appointments

  December 12, 2005

   · 

  3 min read
• Bio NC

  Laboratory Corporation of America Holdings Prices $250 Million In Senior Notes Due 2015

  December 12, 2005

   · 

  1 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: New Data Show Median 30-Month Survival With VELCADE(R) (Bortezomib) For Injection IIn Relapsed Multiple Myeloma

  December 12, 2005

   · 

  7 min read
• Biotech Bay

  Pain Therapeutics Terminates Drug Candidate For The Treatment Of Irritable Bowel Syndrome

  December 12, 2005

   · 

  3 min read
• Policy

  Shire Pharmaceuticals Group plc Release: ADDERALL XR(R) - Further Final Pretrial Conference Set For March 10, 2006. No Trial Date Set

  December 12, 2005

   · 

  2 min read
• Pharm Country

  Alexion Pharmaceuticals Inc. Release: Researchers Identify Pulmonary Hypertension As New, Previously Unrecognized Morbidity Of Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 12, 2005

   · 

  7 min read
• Drug Development

  Amgen Release: New Phase 3 Data Show Potential Benefits Of Aranesp(R) Dosed Every Three Weeks For Chemotherapy-Induced Anemia

  December 12, 2005

   · 

  1 min read
• Drug Development

  Telik, Inc.'s TELINTRA Demonstrates Positive, Clinically Significant Multilineage Responses In Phase 2 MDS Trial

  December 12, 2005

   · 

  3 min read